Himalayan Disaster Response: China says it’s making “every effort” to search for missing people after the Nepal–Tibet mudslide, with Xi Jinping pledging relocation, medical care, and steps to prevent secondary disasters as Nepal’s death toll climbs to 903 and thousands remain missing. Flood Risk Update: China’s water authorities say a barrier lake near the Nepal–China border has drained through natural outflow, easing fears of another sudden downstream flood even as river levels rise again. Rescue Focus on Hydropower Tunnels: Nepal and China teams are racing to reach workers trapped in blocked hydropower tunnels, while warnings of possible fresh flooding add pressure to already strained medical and relief operations. Seasonal Allergy Drug Trial: A China-based phase 2 study reports pumecitinib nasal spray eased nasal and eye symptoms in moderate-to-severe seasonal allergic rhinitis over 14 days, with generally mild side effects. AI in Healthcare: New reporting highlights rapid AI adoption in electronic health records, with China’s AI healthcare market projected to surge and venture funding topping $1B in recent years. Healthcare Security Policy: China’s healthcare security law and related appointments signal tighter national oversight of medical protection. Food Safety Watch: Seoul launches formaldehyde testing for Chinese cabbage and kimchi and intensifies checks at thousands of restaurants and markets after contamination fears. Clinical Pipeline in China: Hutchmed reports positive Phase 3 SANOVO results for ORPATHYS plus TAGRISSO in EGFR-mutant, MET-overexpressing NSCLC in China.